Venrock Healthcare Capital Partners III, affiliates report acquisition of $223,819.75 in Lycia Therapeutics shares

LYCA•2026-11-04

Venrock Healthcare Capital Partners III and affiliated reporting owners acquired 8,305 Lycia Therapeutics common shares at $26.95 each. The group’s indirect beneficial ownership rose to 6,858,542 shares.

Venrock Healthcare Capital Partners III, affiliates report acquisition of $223,819.75 in Lycia Therapeutics shares

1. Share acquisition

Related News

Manulife declares quarterly dividend of C$0.485 per share

Comstock Resources Q3 oil and gas sales $359 million

WesBanco expects Q4 net interest margin of 3.58%-3.60%

Sources

Venrock Healthcare Capital Partners III, affiliates report acquisition of $223,819.75 in Lycia Therapeutics shares

Terreno Realty Q3 revenue beats on new and renewed leases

Nutrien management attributes Q3 2026 earnings decline to lower phosphate and nitrogen earnings